Treatment access is only the first step to hepatitis C elimination: experience of universal anti-viral treatment access in Australia

Hepatitis C virus re-treatment in the era of direct-acting antivirals: projections in the USA

(2018) J. Chhatwal et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Marked reduction in the prevalence of hepatitis C viremia among people who inject drugs during 2nd year of the Treatment as Prevention (TraP HepC) program in Iceland

(2018) T. Tyrfingsson et al.   JOURNAL OF HEPATOLOGY

Hepatitis C care cascade in the country of Georgia after 2 years of starting national hepatitis C elimination program

(2018) T. Tsertsvadze et al.   JOURNAL OF HEPATOLOGY

Eliminating hepatitis C: The importance of frequent testing of people who inject drugs in high-prevalence settings

(2018) Nick Scott et al.   JOURNAL OF VIRAL HEPATITIS

Australia on track to achieve WHO HCV elimination targets following rapid initial DAA treatment uptake: a modeling study

(2018) Jisoo A. Kwon et al.   JOURNAL OF VIRAL HEPATITIS

Strategies to manage hepatitis C virus infection disease burden-Volume 4

(2017) D. S. Chen et al.   JOURNAL OF VIRAL HEPATITIS

Pathways to the elimination of hepatitis C: prioritising access for all

(2017) Alisa E. Pedrana et al.   Expert Review of Clinical Pharmacology

Global, regional, and country-level coverage of interventions to prevent and manage HIV and hepatitis C among people who inject drugs: a systematic review

(2017) Sarah Larney et al.   Lancet Global Health

Limited provision of diagnostic services to Victorians living with hepatitis C antibodies, 2001-2012: a multi-level modelling analysis

(2016) Kathryn Snow et al.   AUSTRALIAN AND NEW ZEALAND JOURNAL OF PUBLIC HEALTH

The effects of needle-sharing and opioid substitution therapy on incidence of hepatitis C virus infection and reinfection in people who inject drugs

(2016) C. K. AITKEN et al.   EPIDEMIOLOGY AND INFECTION

Treatment scale-up to achieve global HCV incidence and mortality elimination targets: a cost-effectiveness model

(2016) Nick Scott et al.   GUT

Cost-effectiveness of treating chronic hepatitis C virus with direct-acting antivirals in people who inject drugs in Australia

(2016) Nick Scott et al.   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

Hepatitis C treatment as prevention of viral transmission and liver-related morbidity in persons who inject drugs

(2015) Anthony Cousien et al.   HEPATOLOGY

Modeling hepatitis C virus transmission among people who inject drugs: Assumptions, limitations and future challenges

(2015) Nick Scott et al.   Virulence

The Cascade of Care for an Australian Community-Based Hepatitis C Treatment Service

(2015) Amanda J. Wade et al.   PLoS One

The impact of injecting networks on hepatitis C transmission and treatment in people who inject drugs

(2014) Margaret Hellard et al.   HEPATOLOGY

Enhanced antiviral treatment efficacy and uptake in preventing the rising burden of hepatitis C-related liver disease and costs in Australia

(2014) William Sievert et al.   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

HCV treatment rates and sustained viral response among people who inject drugs in seven UK sites: real world results and modelling of treatment impact

(2014) N. K. Martin et al.   JOURNAL OF VIRAL HEPATITIS

Hepatitis C disease burden and strategies to manage the burden (Guest Editors Mark Thursz, Gregory Dore and John Ward)

(2014) G. J. Dore et al.   JOURNAL OF VIRAL HEPATITIS

Hepatitis C virus treatment for prevention among people who inject drugs: Modeling treatment scale-up in the age of direct-acting antivirals

(2013) Natasha K. Martin et al.   HEPATOLOGY

Hepatitis C in the United States

(2013) Scott D. Holmberg et al.   NEW ENGLAND JOURNAL OF MEDICINE

Modelling antiviral treatment to prevent hepatitis C infection among people who inject drugs in Victoria, Australia

(2012) Margaret E Hellard et al.   MEDICAL JOURNAL OF AUSTRALIA

Global epidemiology of hepatitis B and hepatitis C in people who inject drugs: results of systematic reviews

(2011) Paul K Nelson et al.   LANCET

Can Hepatitis C virus treatment be used as a prevention strategy? Additional model projections for Australia and elsewhere

(2010) Peter Vickerman et al.   DRUG AND ALCOHOL DEPENDENCE